Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
Clareon PanOptix Pro has half the light scatter of Clareon PanOptix 1-3,*,**
PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics 1-4,*,**,†
Clareon PanOptix Pro provides more uninterrupted light distribution across the full visual range, and is designed for better image contrast 1,††,‡
Article content
TORONTO — Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon ® PanOptix ® Pro intraocular lens (IOL) for cataract patients inCanada. PanOptix Pro leverages proprietary ENLIGHTEN ® NXT Optical technology which delivers the lowest light scatter and highest reported light utilization of any trifocal IOL. 1-3,5-9,**,‡‡ PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics. 1-4,*,**,† These enhancements also provide more uninterrupted light distribution from distance to near, and a 16% increase in optical image contrast between distance and intermediate. 1,††,‡ PanOptix Pro builds on the clinically-proven low visual disturbance profile, high spectacle independence and exceptionally high patient satisfaction of PanOptix. 10-13,§,§§,¶,¶¶ 'Now, with PanOptix Pro, more light utilization and less light scatter is possible‡,‡‡, empowering both my practice and my patients.'
Article content
'As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D,' said Rob Scott, VP, Intraocular Devices, R&D, Alcon. 'Our team looked at hundreds of design options, ultimately landing on a targeted diffractive refinement that helped us recover 50% of light lost to scatter, and reposition it to a beneficial focal point for PanOptix Pro. 1,3,10.14-19,* This allowed for specific enhancements while maintaining the features that have driven the success of PanOptix—the world's most implanted trifocal IOL.' 1-3,20,21,*,**,‡‡,‖,Ω 'PanOptix has been a cornerstone of my cataract practice for eight years,' said Dr. Rosa Braga-Mele, MD, MEd, FRCSC, Professor of Ophthalmology, University of Toronto. 'These lenses have consistently delivered outstanding visual outcomes for my patients 10, 24, § – a low visual disturbance profile 25, ∂ and a happy patient with greater spectacle independence. 23, § So, it's exciting to see this technology evolve to further meet patients' visual expectations. Now, with PanOptix Pro, more light utilization and less light scatter is possible ‡,‡‡, empowering both my practice and my patients.'
Article content
PanOptix Pro will be available in Canada from Alcon in the single-use Clareon AutonoMe ® preloaded delivery system and as well as with the Clareon Monarch ® IV delivery system in early 2026. 22 PanOptix Pro offers a +2.17 diopter intermediate and a +3.25 diopter near add power. Like all Alcon IOLs, PanOptix Pro will be available with blue light and ultraviolet filtering. 22 For surgeons interested in more information on PanOptix Pro, please speak to a local Alcon representative.
Article content
About Clareon PanOptix Pro
Article content
The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the center of the Clareon PanOptix Pro Trifocal IOL allows for better near (reading) vision and intermediate (computer work) vision versus what a monofocal lens would provide. Please consult the Directions for Use regarding indications, precautions, cautions and warnings which is available at ifu.alcon.com.
Article content
About Alcon
Article content
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.ca.
Article content
* PanOptix has 88% light utilization (12% scatter light)/PanOptix Pro 94% light utilization (6% scatter light).
** Based on manufacturer-reported values and respective methodology for Clareon PanOptix, Envista Envy, AT Elana, Gemetric and Rayner.
† For feasible diffractive optics of up to pentafocal design from Krackhardt et al.
†† Simulated photopic through-focus point spread function (light intensity [energy])—polychromatic.
‡ Compared to Clareon PanOptix.
‡‡ Based on bench and vision simulator studies.
§Based on prospective multicenter randomized study at 6 months, significantly more subjects reported not experiencing starburst and glare (p<0.05 n=276).
§§All-implanted analysis set.
¶In response to the IOLSAT questionnaire question 'In the past 7 days, how often did you need to wear eyeglasses to see'?
¶¶Response to the following question on IOLSAT questionnaire (Version 1.0, December 20, 2018) at 6 months post-op 'Given your vision today, if you had to do it all over, would you have the same lenses implanted again?'; n=127.
‖ Based on worldwide IOL unit sales of Clareon PanOptix and AcrySof IQ PanOptix through Q1, 2024.
Ω Severity ratings by phakic patients with simulated implant of Clareon PanOptix Pro and Clareon PanOptix using VirtIOL simulator (n=64).
∂ Based in a meta-analysis of 11 unique clinical studies with 580 patients in 10 different countries, including 'very bothersome' and 'severe' visual disturbances. Clinical studies were performed on the AcrySof IQ PanOptix IOL; AcrySof IQ PanOptix and Clareon PanOptix are optically equivalent.
Article content
References
Article content
Alcon data on file, 2025. REF-25218
Alcon data on file, 2024. REF-25221
Alcon data on file, 2015. REF-08546
Krackhardt U, et al: Upper bound on the diffraction efficiency of phase-only fanout elements. Applied Optics; 1992; 31:27-37.; 10. Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
Muzychuk, A. Defocus Curve Performance of a Novel Hydrophobic Acrylic Trifocal Intraocular Lens: A prospective, Multicenter Canadian Study. ASCRS Annual Meeting, April 5-8, Boston.
Rayner Professional Website. https://rayner.com/en/iol/trifocal/rayone-trifocal/. Accessed September 2024.
Carones F. New Concept of Light Distribution for Bilateral Trifocal IOL Implantation. AAO. 2022;2022:53.
ZEISS AT LISA tri family. Supplement in Cataract and Refractive Surgery Today (Europe), September 2014.
Zeiss Cataract Insights: Laying the Myth or Reality; Digitalization enhances cataract surgery? Supplement in Ophthalmology Times, Europe; May 22, 2024; https://europe.ophthalmologytimes.com/zeiss-cataract-insight-series?page=1. Accessed September 2024.
Kohnen T, Lapid-Gortzak R, Ramamurthy D, et al. Clinical outcomes after bilateral implantation of a diffractive trifocal intraocular lens: A worldwide pooled analysis of prospective clinical investigations. Clinical Ophthalmology. 2023;Volume 17:155-163. doi:10.2147/opth.s377234.
Alcon data on file, 2024. REF-23958.
Alcon data on file, 2018. REF-01475.
Alcon Vision LLC. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL. Product Information. 2021.
Charness N, Dijkstra K, Jastrzembski T, Weaver S, Champion M. Monitor viewing distance for younger and older workers. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2008;52(19):1614- 1617. doi:10.1177/154193120805201965
Government of Canada CC for OH and S. CCOHS: Office ergonomics. Canadian Centre for Occupational Health and Safety. April 25, 2023. Accessed May 9, 2023. https://www.ccohs.ca/oshanswers/ergonomics/office/.
Gundersen K, Potvin R. Trifocal intraocular lenses: A comparison of the visual performance and quality of vision provided by two different lens designs. Clinical Ophthalmology. 2017;Volume 11:1081-1087. doi:10.2147/opth.s136164
Kohnen T, Titke C, Böhm M. Trifocal intraocular lens implantation to treat visual demands in various distances following lens removal. American Journal of Ophthalmology. 2016;161. doi:10.1016/j.ajo.2015.09.030
Lwowski C, Pawlowicz K, Petermann K, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive extended depth-of-focus and trifocal intraocular lenses. Journal of Cataract and Refractive Surgery. 2022;48(4):421-428. doi:10.1097/j.jcrs.0000000000000780
Alcon data on file, 2024. REF-25903
Alcon data on file, 2024. REF-23554
MarketScope LLC. 2023 IOL Market Report: Global Analysis for 2022 to 2028. St. Louis, MO: MarketScope LLC; 2023.
Clareon® PanOptix® Pro Trifocal Hydrophobic Acrylic IOL Model PXYWT0 2024 Directions for Use.
Zhu D, et al. Rate of complete spectacle independence with a trifocal intraocular lens: A systematic literature review and meta-analysis. Ophthalmology and Therapy. 2023;12(2):1157-1171. doi:10.1007/s40123-023-00657-5.Alcon Vision LLC.
Modi S, Lehmann R, Maxwell A, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207. doi:10.1016/j.ophtha.2020.07.015
Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Media Relations
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
15 minutes ago
- CTV News
‘Dig deep': Councillors encouraged to find more savings ahead of budget talks
City councillors are getting a preview of the difficult discussions and decisions to be made during budget deliberations. The governance and priorities committee received its second update on city finances on Wednesday after a grim forecast in June. This time it was presented with 69 options of items which aren't included in the budget but could be prioritized, if council chooses to add them. The chambers were filled with members of Saskatoon's business community looking to make their cases. 'Our message today is simple,' Greater Saskatoon Chamber of Commerce CEO Jason Aebig said. 'From now until November, dig deep and demand better. Put the big brains in your administration to work on finding savings.' In June, the city forecasted property tax increases of 9.9 per cent in 2026 and 7.3 per cent in 2027 if spending were to continue as is. The increases amount to $22 and $18 per month, respectively, for an average assessed home value of $397,000. Council ended that meeting by asking administration to find additional savings to lower a 2025 property tax increase closer to 5 per cent. On Wednesday, dozens of members of both the Greater Saskatoon Chamber of Commerce and the NSBA filled the chambers to stress the importance of a lean budget cycle. 'Our members are clear, the pace of tax increases that we've seen and are projected to see is not sustainable,' NSBA executive director Keith Moen said to the committee. Moen highlighted the importance of A.I., and the effect the technology could have on city finances and staffing. Rather than welcome crops of new hires, Moen urged the city to explore all opportunities to utilize A.I. and save taxpayers' bottom line. 'A.I. represents the third major wave of technological change following the internet and smartphones,' he said. 'Every city employee, including council, should be planning for the future with A.I. in mind, but those who embrace it will help the city deliver better services at a lower cost. Those who don't risk holding us back.' Administration said the city is beginning to use A.I., calling its usage 'a little immature at this time.' A report is being prepared for council over 'the next several months,' but some councillors want to see those opportunities sooner. 'I think that's something that we could accelerate, and the sooner we hear back on that, the better,' Ward 5 Coun. Randy Donauer said. Wednesday's report before councillors was for information purposes only. No decisions were made, but the 69 options split between operating and capital expenditures — which account for a combined spending of $12.7 million in 2026 and $15.2 million in 2027 — not only set the stage for November's budget deliberations, they prioritize spending if councillors look to add. Ward 4 Coun. Troy Davies said policing is his main priority. He has no interest in reducing the police budget. Council previously learned the police budget alone would account for a 4.09 per cent increase to property taxes if approved as is. 'There's not a whole lot of room, other than going back in and cutting services, which might have to occur as well,' Davies said. 'I think everything should be on the table.' Wednesday's discussion ended with Ward 9 Coun. Bev Dubois asking administration to compile a list of items the city pays for which used to be the responsibility of the provincial or federal governments.
Globe and Mail
15 minutes ago
- Globe and Mail
Flow Capital Announces Q2 2025 Financial Results
Loan Interest Revenue up 54% and Recurring Free Cash Flow up 212% year over year TORONTO, ON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW), a leading provider of flexible growth capital and alternative debt solutions, announces its unaudited financial and operating results for the three- and six-month periods ended June 30, 2025. Performance Highlights Three Months Ended June 30, 2025, Compared to Three Months Ended June 30, 2024: 54% increase in Loan Interest Revenue to $3.2 million from $2.1 million 212% increase in recurring free cash flow to $884,129 from $283,036 216% increase in recurring free cash flow per share to $0.0290 from $0.0092 39% increase in total investments value to $72.2 million from $52.0 million $16.3 million in new investments compared to $9.3 million Six Months Ended June 30, 2025, Compared to Six Months Ended June 30, 2024 49% increase in Loan Interest Revenue to $6.1 million from $4.1 million 148% increase in recurring free cash flow to $1.7 million from $698,887 152% increase in recurring free cash flow per share to $0.0567 from $0.0224 39% increase in total investments value to $72.2 million from $52.0 million $19.5 million in new investments compared to $16.0 million 'Q2 2025 represented the 8 th consecutive quarter of loan interest revenue growth. More importantly, we are growing our revenue while consistently generating positive free cash flow, with a total of $884,129 for the quarter compared to only $283,036 a year ago. We believe our continued strong growth indicates the strength of our business model and management's ability to execute on it.' said Alex Baluta, CEO of Flow Capital. Detailed Financial Results are available on our website at or on Click here to view image (1) Recurring Free Cash Flow is an internally defined, non-IFRS measure calculated as loan interest revenue less loan amortization income, one-time payments, salaries, professional fees, office and general administrative expenses, and financing expenses. See the section 'Use of Non-IFRS Financial Measures'. Conference Call Details Flow Capital will host a conference call to discuss these results at 9:30 a.m. Eastern Time, on Thursday August 14, 2025. Participants should call +1 800-717-1738 or +1 289-514-5100 and ask an operator for the Flow Capital Earnings Call, Conference ID 29927. Please dial in 10 minutes prior to the call to secure a line. A replay will be available shortly after the call. To access the replay, please dial +1 888-660-6264 or +1 289-819-1325 and enter passcode 29927#. The replay recording will be available until 11:59 p.m. ET, August 28, 2025. An audio recording of the conference call will be also available on the investors' page of Flow Capital's website at About Flow Capital Flow Capital Corp. is a publicly listed provider of flexible growth and alternative capital solutions dedicated to supporting market-leading high-growth companies. Since its inception in 2018, the company has provided financing to businesses in the US, the UK, and Canada, helping them achieve accelerated growth while minimizing dilution and retaining founder control. Flow Capital focuses on revenue-generating, VC-backed, and founder-owned companies seeking growth capital to drive their continued expansion. Learn more at For further information, please contact: Flow Capital Corp. Alex Baluta Chief Executive Officer alex@ 47 Colborne St, Suite 303, Toronto, Ontario M5E 1P8 Non-IFRS Financial Measures This press release includes references to the non-IFRS financial measure "Recurring Free Cash Flow." This financial measure is employed by the Company to measure its operating and economic performance, to assist in business decision-making, and to provide key performance information to senior management. The Company believes that, in addition to conventional measures prepared in accordance with IFRS, certain investors and analysts use this information to evaluate the company's operating and financial performance. This financial measure is not defined under IFRS, nor does it replace or supersede any standardized measure under IFRS. Other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure. Reconciliations of non-IFRS measures to the nearest IFRS measure can be found in this press release under "Reconciliation of Non-IFRS Measures." Reconciliation of Non-IFRS Measures The table below reconciles Recurring Free Cash Flow for the periods indicated. Recurring Free Cash Flow is an internally defined, non-IFRS measure calculated as loan interest and royalty income less loan amortization income, one-time payments, salaries, professional fees, office and general administrative expenses, and financing expenses. Please click here to view image Forward-Looking Information and Statements Certain statements herein may be 'forward-looking' statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Flow or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward-looking statements. These forward-looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Flow assumes no obligation, except as required by law, to update any forward-looking statements to reflect new events or circumstances.
CTV News
15 minutes ago
- CTV News
Lethbridge Polytechnic receives $1.75-million grant
Lethbridge Polytechnic has received $1.75 million in grant funding from the Natural Sciences and Engineering Research Council of Canada. Lethbridge Polytechnic has received $1.75 million in grant funding. The money comes from the Natural Sciences and Engineering Research Council of Canada. The grant will cover a five-year period. It will go to the polytechnic's Centre for Applied Research, Innovation and Entrepreneurship. The funding will help to grow the Integrated Agriculture Technology Centre. The centre supports agricultural producers in southern Alberta through applied research, consultation and problem-solving. 'The money is intended to go where industry needs the research to go. So, it helps us support industry with what's emerging for them and what's the priorities for them,' said Andrew Dunlop, associate vice-president of research. 'That's pivotal for what we do. It's really the difference between not being able to provide any services for the industry and actually progressing into the next five years and really addressing industry challenges and needs,' said Alexis Buzzee, Integrated Agriculture Technology Centre business manager. This is the second time the polytechnic has received this particular grant.
